| scholarly article | Q13442814 |
| P50 | author | Meir J. Stampfer | Q80164992 |
| Karen H Costenbader | Q87706447 | ||
| Diane Feskanich | Q94147128 | ||
| Elizabeth W Karlson | Q98839527 | ||
| P2093 | author name string | A Elisabeth Hak | |
| P2860 | cites work | Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials | Q24546221 |
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
| Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis | Q33483172 | ||
| Immunology of the antiphospholipid syndrome: antibodies, antigens, and autoimmune response | Q33800265 | ||
| Systemic lupus erythematosus and accelerated atherosclerosis | Q33974673 | ||
| Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
| Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
| Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
| Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time | Q35637820 | ||
| Atherosclerosis in patients with autoimmune disorders | Q36173656 | ||
| Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. | Q36245805 | ||
| Accelerated atherosclerosis in autoimmune rheumatic diseases | Q36318870 | ||
| Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. | Q36591918 | ||
| Reproductive and menopausal factors and risk of systemic lupus erythematosus in women | Q36773713 | ||
| Making the diagnosis of systemic lupus erythematosus in children and adolescents | Q36915623 | ||
| Mortality in systemic lupus erythematosus | Q38467155 | ||
| Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. | Q38479125 | ||
| Reproducibility and Validity of an Expanded Self-Administered Semiquantitative Food Frequency Questionnaire among Male Health Professionals | Q39605930 | ||
| Is atherosclerosis a complication of long-term corticosteroid treatment? | Q39732969 | ||
| Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. | Q41109148 | ||
| The Nurses' Health Study: 20-year contribution to the understanding of health among women | Q41378639 | ||
| Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 | ||
| Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 | ||
| Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study | Q43870770 | ||
| Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study | Q44383942 | ||
| Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. | Q44612340 | ||
| Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study | Q44652580 | ||
| Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction | Q47273525 | ||
| Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. | Q51578946 | ||
| A connective tissue disease screening questionnaire for population studies | Q70785085 | ||
| Test of the National Death Index | Q71344931 | ||
| Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
| Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity | Q75828790 | ||
| P433 | issue | 10 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 1396-1402 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study | |
| P478 | volume | 61 |
| Q38425913 | A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis |
| Q37658524 | Accelerated atherosclerosis in SLE: mechanisms and prevention approaches |
| Q34240254 | Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes |
| Q41919852 | Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark. |
| Q38003593 | Association between polymyalgia rheumatica and vascular disease: a systematic review |
| Q47617910 | Association of Trauma and Posttraumatic Stress Disorder With Incident Systemic Lupus Erythematosus in a Longitudinal Cohort of Women |
| Q36395191 | Association of systemic lupus erythematosus with angiographically defined coronary artery disease: a retrospective cohort study |
| Q87858477 | Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial |
| Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
| Q36995139 | Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus |
| Q27016554 | Cardiovascular disease in lupus: insights and updates |
| Q35121150 | Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions |
| Q21195262 | Cardiovascular disease in systemic sclerosis--an emerging association? |
| Q43885994 | Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q40485054 | Cardiovascular manifestations in systemic lupus erythematosus in Dakar: Descriptive study about 50 cases |
| Q37808570 | Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications |
| Q36680400 | Cardiovascular risk factors in systemic lupus erythematosus |
| Q38124279 | Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery |
| Q64251440 | Catastrophic Antiphospholipid Syndrome Presenting as Congestive Heart Failure in a Patient with Thrombotic Microangiopathy |
| Q36286317 | Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan |
| Q36737988 | Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus |
| Q38034111 | Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction |
| Q36468887 | Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis |
| Q33547420 | Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus |
| Q50571191 | Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. |
| Q46774800 | Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation |
| Q38162490 | Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus |
| Q37587314 | Dynamics of pulse wave velocity and vascular augmentation index in association with endothelial progenitor cells in SLE. |
| Q36079802 | Effect of the Diagnosis of Inflammatory Bowel Disease on Risk-Adjusted Mortality in Hospitalized Patients with Acute Myocardial Infarction, Congestive Heart Failure and Pneumonia |
| Q34072179 | Endothelial dysfunction in chronic inflammatory diseases |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q37930979 | Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians |
| Q38098647 | Examining the risk of cardiovascular disease in patients with psoriasis: a critical review. |
| Q33570432 | Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls |
| Q26801173 | Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease |
| Q38029146 | Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects |
| Q58726963 | Identification of protein complexes associated with myocardial infarction using a bioinformatics approach |
| Q37699812 | Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus. |
| Q26750752 | Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis |
| Q37715144 | Impaired arterial stiffness in systemic lupus ertythematosus - correlations with inflammation markers |
| Q36606667 | Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus |
| Q47439880 | JAK inhibition as a therapeutic strategy for immune and inflammatory diseases |
| Q48556502 | JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. |
| Q37866668 | Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center |
| Q40316468 | Lipid profile among girls with systemic lupus erythematosus |
| Q33437227 | Long-term complications of splenectomy in adult immune thrombocytopenia |
| Q33721199 | Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients |
| Q40134411 | Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis |
| Q34343906 | Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus |
| Q89099489 | Microparticles (CD146) and Arterial Stiffness Versus Carotid Intima Media Thickness as an Early Predictors of Vascular Affection in Systemic Lupus Patients |
| Q60919681 | New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease |
| Q35243557 | No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease |
| Q34440634 | Obesity and its measurement in a community‐based sample of women with systemic lupus erythematosus |
| Q30409882 | Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus |
| Q53694045 | Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus. |
| Q64120434 | Physical Fitness and Body Composition in Women with Systemic Lupus Erythematosus |
| Q48434991 | Physical activity in patients with systemic lupus erythematosus and matched controls |
| Q38156069 | Pragmatic approaches to therapy for systemic lupus erythematosus |
| Q35639129 | Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus |
| Q33387473 | Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study |
| Q39151227 | Prevalence of resting-ECG abnormalities in systemic lupus erythematosus: a single-center experience |
| Q50637234 | Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts. |
| Q39160397 | Psoriasis as a human model of disease to study inflammatory atherogenesis |
| Q48636445 | Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus |
| Q35890096 | Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis |
| Q38175493 | Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies. |
| Q90000657 | Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China |
| Q38404919 | Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study |
| Q38764974 | Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study. |
| Q36299359 | Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study |
| Q47671088 | Sex, Symptom Severity, and Quality of Life in Rheumatology |
| Q35835877 | Statin therapy in lupus-mediated atherogenesis: two birds with one stone? |
| Q26771476 | Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies |
| Q34630261 | Systemic lupus erythematosus and cardiac risk factors: medical record documentation and patient adherence |
| Q38836199 | Targeting vascular (endothelial) dysfunction. |
| Q34512225 | The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors |
| Q39283399 | The evolving concept of SLE comorbidities. |
| Q35169351 | The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus |
| Q35283742 | The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study |
| Q39039774 | The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study |
| Q40910621 | The vascular phenotype of children with systemic lupus erythematosus |
| Q50092295 | Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014). |
| Q33818710 | Use of atorvastatin in systemic lupus erythematosus in children and adolescents |
| Q89647402 | Utility of Coronary Calcium Scoring (CCS) in Connective Tissue Disorders (CTDs) for the Evaluation of Subclinical Coronary Atherosclerosis - A Systematic Review |
| Q92156078 | Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease |
| Q38591752 | Why are kids with lupus at an increased risk of cardiovascular disease? |
Search more.